Strategic partnership marks advent of new technologies
AstraZeneca UK has entered into a strategic relationship with Advent International Corporation, a large global private equity house that aims to help build market-leading businesses in Europe, North America, Latin America and Asia Pacific.
AstraZeneca UK has entered into a strategic relationship with Advent International Corporation, a large global private equity house that aims to help build market-leading businesses in Europe, North America, Latin America and Asia Pacific.
The goal of the partnership is to identify and evaluate emerging technologies. Representatives from AstraZeneca's Discovery and Business Development groups will work closely with Advent's Boston-based healthcare team in evaluating emerging opportunities and transactions with companies in the health care and life sciences industry.